Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum

NEXT STORY
AREV’s Nanotech initiates early-stage antiviral photochemistry derivation discovery program for pandemic viral pathogens
PREV STORY
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cellectis Appoints Pharma HR Leader Kyung Nam-Wortman as Executive Vice President, Chief Human Resources Officer

author_avatar
NASDAQ Market News

ChemoCentryx Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights

-- Phase III ADVOCATE trial of avacopan in treatment of ANCA vasculitis nears 75% ...

author_avatar
NASDAQ Market News

Erasca Announces FDA Clearance of IND Application for ERAS-801 in Glioblastoma Multiforme and Collaboration with GCAR for Potential Inclusion in GBM AGILE Clinical Trial

author_avatar
NASDAQ Market News